Emergency presenting colon cancer is an independent predictor of adverse disease-free survival

International Surgery

Volumn 100, Issue 1, 2015, Pages 77-86

  Hogan, John ^a   Samaha, Georges ^b   Burke, John ^a   Chang, Kah Hoong ^a   Condon, Eoghan ^a   Waldron, David ^a   Coffey, John Calvin ^a,c  

^a UNIVERSITY HOSPITAL LIMERICK   (Ireland)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c UNIVERSITY OF LIMERICK   (Ireland)

Author keywords

Colon cancer; Disease free survival; Emergency presentation; Locoregional recurrence

Indexed keywords

ADENOCARCINOMA; AGED; CANCER STAGING; COLON RESECTION; COLONIC NEOPLASMS; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; EMERGENCY; ETIOLOGY; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; MALE; METASTASIS; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADENOCARCINOMA; AGED; COLECTOMY; COLONIC NEOPLASMS; DISEASE-FREE SURVIVAL; EMERGENCIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84975089815     PISSN: 00208868     EISSN: None     Source Type: Journal    
DOI: 10.9738/INTSURG-D-13-00281.1     Document Type: Article

References (28)

1. Canna K, Hilmy M, McMillan DC, Smith GW, McKee RF, McArdle CS et al. The relationship between tumour proliferative activity, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Colorectal Dis 2008;10(7):663-667
2. Bowel Cancer UK. Bowel cancer statistics. Bowel Cancer UK. Available at: http://www.bowelcanceruk.org.uk/resources/bowel-cancer-facts-figures. Accessed March 31, 2014.
3. Bass G, Flemming C, Conneely J, Martin M, Mealy K. Emergency first presentation of colorectal cancer predicts significantly poorer outcomes. Dis Colon Rectum 2009;52(4):678-684
4. Charbonnet P, Gervaz P, Andres A, Bucher P, Konrad B, Morel P. Results of emergency Hartmann's operation for obstructive or perforated left-sided colorectal cancer. World J Surg Oncol. 2008;23(6):90
5. McArdle CS, Hole DJ. Emergency presentation of colorectal cancer is associated with poor 5-year survival. Br J Surg 2004;91(5):605-609
6. Zuli Y, Wang L, Kang L, Xiang Y, Peng J, Cui J et al. Clinicopathologic characteristics and outcomes of patients with obstructive colorectal cancer. J Gastrointest Surg 2011;15(7):1213-1222
7. Abdelrazeq AS, Scott N, Thorn C, Verbeke CS, Ambrose NS, Botelli ID et al. The impact of spontaneous tumor perforation on outcome following colon cancer surgery. Colorectal Dis 2008;10(8):775-780
8. Pinheiro M, Ahlquist T, Danielsen SA, Lind GE, Veiga I, Pinto C et al. Colorectal carcinomas with microsatellite instability display a different pattern of target gene mutations according to large bowel site of origin. BMC Cancer 2010;10:587.
9. Rosenberg R, Nekarda H, Zimmermann F, Becker K, Lordick F, Hofler H et al. Histopathological response after preoperative radiochemotherapy in rectal carcinoma is associated with improved overall survival. J Surg Oncol 2008;97(1):8-13
10. Li JN, Zhao L, Wu J, Wu B, Yang H, Zhang HH et al. Differences in gene expression profiles and carcinogenesis pathways between colon and rectal cancer. J Dig Dis 2012;13(1):24-32
11. Frattini M, Balestra D, Suardi S, Oggionni M, Alberici P, Radice P et al. Different genetic features associated with colon and rectal carcinogenesis. Clin Cancer Res 2004;10(12 Pt 1):4015-4021
12. Alvarez JA, Baldonedo RF, Bear IG, Truán N, Pire G, Alvarez P. Presentation, treatment, and multivariate analysis of risk factors for obstructive and perforative colorectal carcinoma. Am J Surg 2005;190(3):376-382
13. Luigi Z, Rosman A, Restivo A, Pisano M, Nigri G, Fancellu G et al. Complete pathologic response after combined modality treatment for rectal cancer and long-term survival: a meta-analysis. Ann Surg Oncol 2012;19(9):2822-2832
14. Willem VG, Marijnen CA, Nagtegaal ID, Kranenbarg E, Putter H, Wiggers T et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 2011;12 (6):575-582
15. Terry PP, MacFarlane JK, Taylor RH, Cheifetz R, Davis N, Hay J et al. Effect of emergent presentation on outcome from rectal cancer management. Am J Surg 2003;185(5):450-454
16. Biondo S, Navarro M, Marti-Rague J, Arriola E, Pares D, Del Rio C et al. Response to neoadjuvant therapy for rectal cancer: influence on long-term results. Colorectal Dis 2005;7(5):472-479
17. Culligan K, Remzi FH, Soop M, Coffey JC. Review of nomenclature in colonic surgery-proposal of a standardized nomenclature based on mesocolic anatomy. Surgeon 2013;11(1):1-5
18. Kessaf A, Özdemir S, Mahmoudi H, Kuzu M. Analysis of 230 cases of emergent surgery for obstructing colon cancer - lessons learned. J Gastrointest Surg 2011;15(1):110-119
19. Siu Kin CW, Jalaludin B, Morgan M, Berthelsen A, Morgan A, Gatenby A et al. Tumor pathology and long-term survival in emergency colorectal cancer. Dis Colon Rectum 2008;51(20):223-230
20. Sjo OH, Larsen S, Lunde OC, Nesbakken A. Short term outcome after emergency and elective surgery for colon cancer. Colorectal Dis. 2009;11(7):733-739
21. Pavlidis T, Marakis G, Ballas K, Rafailidis S, Psarras K, Pissas D et al. Does emergency surgery affect resectability of colorectal cancer? Acta Chirurgica Belgica. 2008;108(2):219-225
22. Burton S, Norman A, Brown A, Abulafi A, Swift R. Predictive poor prognostic factors in colonic carcinoma. Surg Oncol 2006;15(2):71-78
23. Sjovall A, Granath F, Cedermark B, Glimelius B, Holm T. Locoregional recurrence from colon cancer: a population based study. Ann Surg Oncol 2007;14(2):434-440
24. Gill S, Loprinzi CL, Sargent DJ, Thome SD, Alberts SR, Haller DG et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol 2004;22(10):1797-1806
25. Barrier A, Boelle BY, Roser F, Gregg J, Tse C, Brault D et al. Stage II colon cancer prediction by tumor gene expression profiling. J Clin Oncol 2006;24(29):4685-4691
26. Benson AL, Schrag D, Somerfield MR, Cohen AM, Figuerdo AT, Flynn PJ et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 2004;22(16):3408-3419
27. Kraemer M, Wiratkapun S, Seow-Choen F, Ho YH, Eu KW, Nyam D. Stratifying risk factors for follow-up: a comparison of recurrent and nonrecurrent colorectal cancer. Dis Colon Rectum 2001;44(6):815-821
28. Figuerdo A, Charette ML, Maroun J, Brouwers MC, Zuraw L. Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group. J Clin Oncol 2004;22(16):3395-3407